Pyrimidine

Pyrimidine

SCHEMBL8355332

C=CF.c1cncnc1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyrimidine SCHEMBL9216454 0.83 TSHR (0.35)
Pyrimidine SCHEMBL27645497 0.80
Pyrimidine SCHEMBL27571435 0.78
Pyrimidine SCHEMBL10646 0.78 TSHR (0.50)
Pyrimidine SCHEMBL1846 0.78
Pyrimidine SCHEMBL19437633 0.78 TSHR (0.50)
Pyrimidine SCHEMBL3320082 0.75 TSHR (0.30)
Pyrimidine SCHEMBL2218253 0.75 TSHR (0.47)
Pyrimidine SCHEMBL19876786 0.74 TSHR (0.40)
Pyrimidine SCHEMBL28761784 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999029702-A2 METHOD FOR SYNTHESIZING 9-(2,3-DIDEOXY-2-FLUORO-β-D-THREO-PENTOFURANOSYL)ADENINE (β-FddA) THE GOVERNMENT OF THE UNITED STATES OF AMERICA REPPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-06-17 WO disclosed